Top Markets
Coin of the day
PacificHealth Laboratories, Inc. PacificHealth Laboratories, Inc.

PacificHealth Laboratories, Inc.

PHLI
Classificação em ações #39566
PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing... PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery. PHLI's product line includes notable items like ENDUROX R4, a drink formulated for muscle recovery; ACCELERADE, a protein-powered sports beverage; energy gels such as ACCEL GEL and 2ND SURGE; the exercise supplement ENDUROX EXCEL; and Body Glove Surge. Additionally, they provide ACCELERADE HYDRO, a specific formulation for less intense workouts, which supports hydration, energy, and recovery before, during, and after physical activity. Reaching consumers through diverse distribution channels, PHLI's products are available in sports specialty and natural product retailers and chains, as well as directly through their official website. PacificHealth Laboratories, Inc. was founded in 1995 and is headquartered in Matawan, New Jersey.
Preço da ação
$0.0001
Última sincronização: 2025-02-11
Valor de mercado
$438.31K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar PacificHealth Laboratories, Inc. (PHLI)
EPS de PacificHealth Laboratories, Inc. (PHLI)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da PacificHealth Laboratories, Inc., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da PacificHealth Laboratories, Inc. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes